Vital Farms Reports Third Quarter 2021 Financial Results
Vital Farms reported record net revenue of $64.6 million for Q3 2021, marking a 21.1% increase from Q3 2020. The company expanded its farm network to over 250 farms and retail distribution to over 18,000 stores. However, a net loss of $1.3 million was reported, with an adjusted EBITDA of $0.2 million. For the full year 2021, Vital Farms raised its revenue guidance to between $253 to $256 million, reflecting strong growth momentum despite rising grain costs and increased operating expenses.
- Record net revenue of $64.6 million, up 21.1% YoY.
- Raised fiscal 2021 net revenue guidance to $253-$256 million, an 18-19% increase over 2020.
- Increased network of family farms to over 250 and distribution to over 18,000 stores.
- Net loss of $1.3 million compared to net income of $1.7 million in the prior year.
- Adjusted EBITDA declined to $0.2 million from $3.7 million a year ago due to higher costs.
Record Net Revenue of
Increasing 2021 Net Revenue Guidance
AUSTIN, Texas, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced pasture-raised foods nationwide, today reported financial results for its third quarter ended September 26, 2021.
Financial highlights for the third quarter of 2021 include:
- Net Revenue increases
21.1% to$64.6 million - Net Loss of
$1.3 million - Adjusted EBITDA of
$0.2 million 1
“We delivered record net revenue for the second consecutive quarter, increased our network of family farms to over 250, expanded retail distribution to over 18,000 stores, and over 5.5 million households continue to trust our pasture-raised eggs,” said Russell Diez-Canseco, President and CEO, Vital Farms.
“We are pleased to raise our fiscal year revenue outlook which reflects our confidence in sustaining the strong momentum we’ve seen across the business.”
Diez-Canseco continued, “We believe our financial performance and continued growth is a testament to how we operate the business in the interest of our stakeholders—farmers, suppliers, crew members, customers, consumers, communities, environment, and stockholders—a model that not only promises resilience to these core groups but also produces robust returns over time.”
For the Three Months Ended September 26, 2021
Net revenue increased
Gross profit was
Loss from operations in the third quarter of 2021 was
Net loss was
Net loss per diluted share was (
Adjusted EBITDA was
Balance Sheet and Cash Flow Highlights
Vital Farms’ cash and cash equivalents and investment securities were
Capital expenditures totaled
Bo Meissner, Chief Financial Officer commented, “We are pleased with our record third quarter revenue and our two-year CAGR of
Update on Fiscal 2021 Outlook
Vital Farms’ guidance continues to assume that there are no additional significant disruptions to the supply chain, or its customers or consumers, including any issues from adverse macroeconomic factors.
- For the full year 2021, management now expects net revenue between
$253 t o$256 million , an increase of 18-19% compared to 2020. - Management is also tightening its expectation on Adjusted EBITDA and anticipates it will be in the range of
$8 t o$9 million for the full year 2021.
Vital Farms cannot provide a reconciliation between its forecasted Adjusted EBITDA and net revenue metrics without unreasonable effort due to the unavailability of reliable estimates for certain items. These items are not within our control and may vary greatly between periods and could significantly impact future financial results.
Conference Call and Webcast Details
Vital Farms will host a conference call and webcast at 8:30 a.m. ET today to discuss the results. The live conference call can be accessed by dialing (833) 519-1345 from the U.S. or (914) 800-3907 internationally and using access code 4665467. Alternatively, participants may access the live webcast on the Vital Farms Investor Relations website at https://investors.vitalfarms.com under “Events.” The webcast will be archived in 30 days.
About Vital Farms
Vital Farms, a Certified B Corporation, offers a range of ethically produced pasture-raised foods nationwide. Started on a single farm in Austin, Texas, in 2007, Vital Farms is now a national consumer brand that works with over 250 small family farms and is the leading U.S. brand of pasture-raised eggs and butter by retail dollar sales. Vital Farms' ethics are exemplified by its focus on the humane treatment of farm animals and sustainable farming practices. In addition, as a Delaware Public Benefit Corporation, Vital Farms prioritizes the long-term benefits of each of its stakeholders, including farmers and suppliers, customers and consumers, communities and the environment, and crew members and stockholders. Vital Farms' pasture-raised products, including shell eggs, butter, hard-boiled eggs, ghee, egg bites and liquid whole eggs, are sold in over 18,000 stores nationwide. For more information, visit www.vitalfarms.com.
Forward-Looking Statements
This press release and the earnings call referencing this press release contain “forward-looking” statements, as that term is defined under the federal securities laws, including but not limited to statements regarding Vital Farms’ market opportunity, anticipated growth, and future financial performance, including management’s outlook for fiscal year 2021. These forward-looking statements are based on Vital Farms’ current assumptions, expectations and beliefs and are subject to substantial risks, uncertainties, assumptions, and changes in circumstances that may cause Vital Farms’ actual results, performance, or achievements to differ materially from those expressed or implied in any forward-looking statement.
The risks and uncertainties referred to above include, but are not limited to: the effects of the current COVID-19 pandemic on Vital Farms’ supply chain, the demand for its products, and on overall economic conditions and consumer confidence and spending levels; Vital Farms’ expectations regarding its revenue, expenses and other operating results; Vital Farms’ ability to acquire new customers, to successfully retain existing customers and to attract and retain its suppliers, distributors and co-manufacturers; Vital Farms’ ability to sustain or increase our profitability; Vital Farms’ ability to procure sufficient high quality eggs, cream and other raw materials; real or perceived quality with Vital Farms’ products or other issues that adversely affect Vital Farms’ brand and reputation; changes in the tastes and preferences of consumers; the financial condition of, and Vital Farms’ relationships with, its suppliers, co-manufacturers, distributors, retailers and foodservice customers, as well as the health of the foodservice industry generally; the ability of Vital Farms’ suppliers and co-manufacturers to comply with food safety, environmental or other laws or regulations; future investments in its business, anticipated capital expenditures and estimates regarding capital requirements; the costs and success of marketing efforts. Vital Farms’ ability to effectively manage its growth and to compete effectively with existing competitors and new market entrants; the potential negative impact of Vital Farms’ focus on a specific public benefit purpose and producing a positive effect for society on its financial performance; seasonality; and the growth rates of the markets in which Vital Farms competes.
These risks and uncertainties are more fully described in Vital Farms’ filings with the Securities and Exchange Commission, including in the section entitled “Risk Factors” in its Quarterly Report on Form 10-Q for the fiscal quarter ended June 27, 2021, and other filings and reports that Vital Farms may file from time to time with the SEC. Moreover, Vital Farms operates in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for management to predict all risks, nor can Vital Farms assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements Vital Farms may make. In light of these risks, uncertainties and assumptions, Vital Farms cannot guarantee future results, levels of activity, performance, achievements, or events and circumstances reflected in the forward-looking statements will occur. Forward-looking statements represent managements’ beliefs and assumptions only as of the date of this press release. Vital Farms disclaims any obligation to update forward-looking statements except as required by law.
Contacts:
Media:
Nisha Devarajan
Nisha.Devarajan@vitalfarms.com
Investors:
Matt Siler
Matt.Siler@vitalfarms.com
VITAL FARMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except share amounts)
(Unaudited)
| 13-Weeks Ended | 39-Weeks Ended | |||||||||||||||
| September 27, | September 27, | September 27, | September 27, | |||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Net revenue | $ | 64,627 | $ | 53,367 | $ | 183,496 | $ | 160,287 | ||||||||
| Cost of goods sold | 44,788 | 35,017 | 120,394 | 103,384 | ||||||||||||
| Gross profit | 19,839 | 18,350 | 63,102 | 56,903 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Selling, general and administrative | 15,326 | 12,185 | 42,053 | 31,832 | ||||||||||||
| Shipping and distribution | 6,318 | 3,752 | 16,755 | 10,693 | ||||||||||||
| Total operating expenses | 21,644 | 15,937 | 58,808 | 42,525 | ||||||||||||
| (Loss) income from operations | (1,805 | ) | 2,413 | 4,294 | 14,378 | |||||||||||
| Other (expense) income, net: | ||||||||||||||||
| Interest expense | (11 | ) | (110 | ) | (42 | ) | (365 | ) | ||||||||
| Other income (expense), net | 2 | (21 | ) | 300 | (182 | ) | ||||||||||
| Total other (expense) income, net | (9 | ) | (131 | ) | 258 | (547 | ) | |||||||||
| Net (loss) income before income taxes | (1,814 | ) | 2,282 | 4,552 | 13,831 | |||||||||||
| (Benefit) provision for income taxes | (486 | ) | 620 | (1,485 | ) | 4,300 | ||||||||||
| Net (loss) income | (1,328 | ) | 1,662 | 6,037 | 9,531 | |||||||||||
| Less: Net loss attributable to noncontrolling interests | (6 | ) | (15 | ) | (41 | ) | (54 | ) | ||||||||
| Net (loss) income attributable to Vital Farms, Inc. common stockholders | $ | (1,322 | ) | $ | 1,677 | $ | 6,078 | $ | 9,585 | |||||||
| Net (loss) income per share attributable to Vital Farms, Inc. stockholders: | ||||||||||||||||
| Basic: | $ | (0.03 | ) | $ | 0.05 | $ | 0.15 | $ | 0.33 | |||||||
| Diluted: | $ | (0.03 | ) | $ | 0.04 | $ | 0.14 | $ | 0.29 | |||||||
| Weighted average common shares outstanding: | ||||||||||||||||
| Basic: | 40,196,410 | 34,044,994 | 39,910,063 | 28,664,914 | ||||||||||||
| Diluted: | 40,196,410 | 39,111,018 | 43,380,711 | 33,275,902 | ||||||||||||
VITAL FARMS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share amounts)
| September 26, | December 27, | |||||||
| 2021 | 2020 | |||||||
| (Unaudited) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 27,844 | $ | 29,544 | ||||
| Investment securities | 69,805 | 68,357 | ||||||
| Accounts receivable, net | 22,302 | 20,934 | ||||||
| Inventories | 14,578 | 12,902 | ||||||
| Income taxes receivable | 1,339 | 1,554 | ||||||
| Prepaid expenses and other current assets | 4,784 | 3,965 | ||||||
| Total current assets | 140,652 | 137,256 | ||||||
| Property, plant and equipment, net | 42,169 | 30,118 | ||||||
| Goodwill | 3,858 | 3,858 | ||||||
| Deposits | 256 | 142 | ||||||
| Total assets | $ | 186,935 | $ | 171,374 | ||||
| Liabilities, Redeemable Noncontrolling Interest and Stockholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 17,368 | $ | 15,489 | ||||
| Accrued liabilities | 14,465 | 9,845 | ||||||
| Lease obligation, current | 447 | 471 | ||||||
| Contingent consideration, current | 35 | 109 | ||||||
| Total current liabilities | 32,315 | 25,914 | ||||||
| Lease obligation, net of current portion | — | 327 | ||||||
| Contingent consideration, non-current | — | 18 | ||||||
| Deferred tax liabilities, net | 849 | 2,537 | ||||||
| Other liability, non-current | 191 | 192 | ||||||
| Total liabilities | 33,355 | 28,988 | ||||||
| Commitments and contingencies (Note 15) | ||||||||
| Redeemable noncontrolling interest | 175 | 175 | ||||||
| Stockholders’ equity: | ||||||||
| Common stock, | 5 | 5 | ||||||
| Treasury stock, at cost, zero and 5,494,918 common shares as of September 26, 2021 (unaudited) and December 27, 2020, respectively (Note 11) | — | (16,276 | ) | |||||
| Additional paid-in capital | 146,983 | 144,311 | ||||||
| Retained earnings | 6,395 | 14,039 | ||||||
| Accumulated other comprehensive loss | (100 | ) | (31 | ) | ||||
| Total stockholders’ equity attributable to Vital Farms, Inc. stockholders | 153,283 | 142,048 | ||||||
| Noncontrolling interests | 122 | 163 | ||||||
| Total stockholders’ equity | $ | 153,405 | $ | 142,211 | ||||
| Total liabilities, redeemable noncontrolling interest, and stockholders’ equity | $ | 186,935 | $ | 171,374 | ||||
VITAL FARMS, INC.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Amounts in thousands)
(Unaudited)
| 39-Weeks Ended | ||||||||
| September 26, | September 27, | |||||||
| 2021 | 2020 | |||||||
| Cash flows provided by operating activities: | ||||||||
| Net income | $ | 6,037 | $ | 9,531 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 2,526 | 1,568 | ||||||
| Non-cash interest expense | — | 5 | ||||||
| Bad debt expense (recovery) | 65 | (63 | ) | |||||
| Inventory provisions | 186 | 155 | ||||||
| Change in fair value of contingent consideration | 34 | (342 | ) | |||||
| Stock-based compensation expense | 3,192 | 1,481 | ||||||
| Loss on disposal of property, plant and equipment | 108 | 259 | ||||||
| Deferred taxes | (1,688 | ) | 1,382 | |||||
| Non-cash interest income | (190 | ) | (14 | ) | ||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (1,433 | ) | (1,380 | ) | ||||
| Inventories | (1,862 | ) | 1,063 | |||||
| Income taxes receivable | 214 | 1,293 | ||||||
| Income taxes payable | — | 364 | ||||||
| Prepaid expenses and other current assets | (818 | ) | (1,970 | ) | ||||
| Deposits and other assets | (114 | ) | 11 | |||||
| Accounts payable | 1,385 | 2,207 | ||||||
| Accrued liabilities and other liabilities | 4,626 | (507 | ) | |||||
| Net cash provided by operating activities | $ | 12,268 | $ | 15,043 | ||||
| Cash flows used in investing activities: | ||||||||
| Purchases of property, plant and equipment | (14,192 | ) | (6,728 | ) | ||||
| Purchases of available-for-sale debt securities | (43,363 | ) | — | |||||
| Sales, maturities, and call redemptions of available-for-sale debt securities | 42,029 | — | ||||||
| Repayment of notes receivable provided to related parties | — | 846 | ||||||
| Net cash used in investing activities | $ | (15,526 | ) | $ | (5,882 | ) | ||
| Cash flows provided by financing activities: | ||||||||
| Proceeds from issuance of common stock pursuant to the initial public offering, net of issuance costs | — | 99,671 | ||||||
| Proceeds from borrowings under term loan | — | 5,000 | ||||||
| Proceeds from borrowings under equipment loan | — | 1,461 | ||||||
| Proceeds from Paycheck Protection Program loan | — | 2,593 | ||||||
| Repayment of revolving line of credit | — | (1,325 | ) | |||||
| Repayment of equipment loan | — | (2,015 | ) | |||||
| Repayment of term loan | — | (618 | ) | |||||
| Repayment of Paycheck Protection Program loan | — | (2,593 | ) | |||||
| Payment of contingent consideration | (126 | ) | (140 | ) | ||||
| Principal payments under finance lease obligation | (351 | ) | (335 | ) | ||||
| Proceeds from exercise of stock options | 2,035 | 203 | ||||||
| Proceeds from exercise of warrant | — | 282 | ||||||
| Net cash provided by financing activities | $ | 1,558 | $ | 102,184 | ||||
| Net (decrease) increase in cash and cash equivalents | (1,700 | ) | 111,345 | |||||
| Cash and cash equivalents at beginning of the period | 29,544 | 1,274 | ||||||
| Cash and cash equivalents at end of the period | 27,844 | 112,619 | ||||||
| Supplemental disclosure of cash flow information: | ||||||||
| Cash paid for interest | $ | 38 | $ | 358 | ||||
| Cash paid for income taxes | $ | 4 | $ | 1,150 | ||||
| Supplemental disclosure of non-cash investing and financing activities: | ||||||||
| Purchases of property, plant and equipment included in accounts payable and accrued liabilities | $ | 494 | $ | 331 | ||||
Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. However, management believes that Adjusted EBITDA, a non-GAAP financial measure, provides investors with additional useful information in evaluating our performance.
Adjusted EBITDA is a financial measure that is not required by or presented in accordance with GAAP. We believe that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as it is a measure used by management in assessing the health of our business, determining incentive compensation and evaluating our operating performance, as well as for internal planning and forecasting purposes.
We calculate Adjusted EBITDA as net income, adjusted to exclude: (1) depreciation and amortization; (2) provision for income taxes; (3) stock-based compensation expense; (4) interest expense; (5) change in fair value of contingent consideration; (6) interest income; and (7) net litigation settlement gain.
Adjusted EBITDA is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of Adjusted EBITDA include that (1) it does not properly reflect capital commitments to be paid in the future, (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures, (3) it does not consider the impact of stock-based compensation expense, (4) it does not reflect other non-operating expenses, including interest expense, (5) it does not consider the impact of any contingent consideration liability valuation adjustments and (6) it does not reflect tax payments that may represent a reduction in cash available to us. In addition, our use of Adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA in the same manner, limiting its usefulness as a comparative measure. Because of these limitations, when evaluating our performance, you should consider Adjusted EBITDA alongside other financial measures, including our net income and other results stated in accordance with GAAP.
The following table presents a reconciliation of Adjusted EBITDA to net income (loss), the most directly comparable financial measure stated in accordance with GAAP, for the 13-week and 39-week periods presented:
VITAL FARMS, INC.
ADJUSTED EBITDA RECONCILIATION
(Amounts in thousands)
(Unaudited)
| 13-Weeks Ended | 39-Weeks Ended | |||||||||||||||
| September 26, | September 27, | September 26, | September 27, | |||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Net (loss) income | $ | (1,328 | ) | $ | 1,662 | $ | 6,037 | $ | 9,531 | |||||||
| Depreciation and amortization | 907 | 614 | 2,527 | 1,568 | ||||||||||||
| (Benefit) provision for income tax | (486 | ) | 620 | (1,485 | ) | 4,300 | ||||||||||
| Stock-based compensation expense | 1,198 | 737 | 3,192 | 1,481 | ||||||||||||
| Interest expense | 11 | 110 | 42 | 365 | ||||||||||||
| Change in fair value of contingent consideration(1) | 14 | 8 | 34 | (342 | ) | |||||||||||
| Interest income | (95 | ) | (10 | ) | (280 | ) | (24 | ) | ||||||||
| Net litigation settlement gain | — | — | — | (20 | ) | |||||||||||
| Adjusted EBITDA | $ | 221 | $ | 3,741 | $ | 10,067 | $ | 16,859 | ||||||||
(1) Amount reflects the change in fair value of a contingent consideration liability in connection with our 2014 acquisition of certain assets of Heartland Eggs
FAQ
What were Vital Farms' Q3 2021 financial results?
What is Vital Farms' revenue guidance for 2021?
Did Vital Farms report a profit or loss in Q3 2021?
What was the adjusted EBITDA for Vital Farms in Q3 2021?
